Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease
Not Applicable
Not yet recruiting
- Conditions
- Copd
- Registration Number
- NCT04260243
- Lead Sponsor
- Cardenal Herrera University
- Brief Summary
The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).
- Detailed Description
So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease.
Aim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease.
Design: Randomized clinical trial
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- COPD;
- Forced expiratory volume in the first second (FEV1) < 80%;
- FEV1/Forced vital capacity (FVC) < 70%;
- Maximal inspiratory pressure (MIP) < 70%.
Exclusion Criteria
- Recent (6 months) spine or abdominal surgery;
- Allergic status of any kind;
- systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
- neuromuscular or neurological injuries;
- previous myofascial release treatment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score 3 weeks Score (0-40) higher scores mean a worse outcome.
- Secondary Outcome Measures
Name Time Method 6 Minutes Walking Test 3 weeks Maximum distance reached